Condition: Postpartum Depression (PPD) · Postpartum Anxiety · Postpartum Sadness · Sponsor: University Hospital Tuebingen
The aim of the study is to explore whether transcutaneous vagus nerve stimulation (tVNS) may be effective in preventing mood swings and depressive symptoms in the postpartum phase, as well as serving as a supplementary intervention in cases where mood symptoms develop. The study will investigate the effects of tVNS intervention during the first 12 weeks postpartum. Pregnant women will be recruited for the study, and the intervention will begin shortly after giving birth. Participants will receive different instructions on how to use the tVNS device. Additional parameters such as physiological functions, chronic stress, hormones, environment, and personality traits will also be assessed.
This description comes directly from the study's public registry record.
Julia Siodmiak, M.sc. · +49 (0)7071 29-85736 · julia.siodmiak@med.uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| University Hospital Tuebingen; Department of Psychiatry and Psychotherapy | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06682689